Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoping Hu

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 24, 2017
Discovery and optimization of selective FGFR4 inhibitors via scaffold hoppingYikai Wang, Zhengxia Chen, Meibi Dai, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2017
Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesiaMingxing Teng, Wentao Wu, Zhixiang Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2020
Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)Jiaqiang Dong, Tie-Lin Wang, Jianyu Lu, et al.
National Science Review|October 3, 2025
Cell-GraphCompass: modeling single cells with graph structure foundation modelChen Fang, Wentao Cui, Zhilong Hu, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMDPeng Li, Jun Yu, Fei Hao, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2016
Design, synthesis, and biological evaluation of anti-EV71 agentsPeng Li, Bailing Yang, Fei Hao, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Discovery and Evaluation of Pyrazolo[3,4-<i>d</i>]pyridazinone as a Potent and Orally Active Irreversible BTK InhibitorXuejun Zhang, Xijun Sheng, Jie Shen, et al.
Respiratory Research|April 6, 2026
TRPC6 mediates goblet cell differentiation in COPDHaiqing Li, Guoping Hu, Lizhi Huang, et al.
Nature Communications|September 30, 2024
Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trialYumin Zhou, Fan Wu, Zhe Shi, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|April 24, 2017
Discovery and optimization of selective FGFR4 inhibitors via scaffold hoppingYikai Wang, Zhengxia Chen, Meibi Dai, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2017
Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesiaMingxing Teng, Wentao Wu, Zhixiang Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2020
Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)Jiaqiang Dong, Tie-Lin Wang, Jianyu Lu, et al.
National Science Review|October 3, 2025
Cell-GraphCompass: modeling single cells with graph structure foundation modelChen Fang, Wentao Cui, Zhilong Hu, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMDPeng Li, Jun Yu, Fei Hao, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2016
Design, synthesis, and biological evaluation of anti-EV71 agentsPeng Li, Bailing Yang, Fei Hao, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Discovery and Evaluation of Pyrazolo[3,4-<i>d</i>]pyridazinone as a Potent and Orally Active Irreversible BTK InhibitorXuejun Zhang, Xijun Sheng, Jie Shen, et al.
Respiratory Research|April 6, 2026
TRPC6 mediates goblet cell differentiation in COPDHaiqing Li, Guoping Hu, Lizhi Huang, et al.
Nature Communications|September 30, 2024
Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trialYumin Zhou, Fan Wu, Zhe Shi, et al.
Pageof 9